National Health Investors (National Health Investors) Change In Receivables

: $0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 1991. Start your Free Trial

National Health Investors's change in receivables for the quarter that ended in Dec. 2023 was $0.0 Mil. It means National Health Investors's Accounts Receivable stayed the same from Sep. 2023 to Dec. 2023 .

National Health Investors's change in receivables for the fiscal year that ended in Dec. 2023 was $0.0 Mil. It means National Health Investors's Accounts Receivable stayed the same from Dec. 2022 to Dec. 2023 .

National Health Investors's Accounts Receivable for the quarter that ended in Dec. 2023 was $89.6 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. National Health Investors's Days Sales Outstanding for the three months ended in Dec. 2023 was 102.92.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. National Health Investors's liquidation value for the three months ended in Dec. 2023 was $-1,124.9 Mil.

National Health Investors Change In Receivables Historical Data

The historical data trend for National Health Investors's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Health Investors Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

National Health Investors Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

National Health Investors Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

National Health Investors (NYSE:NHI) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

National Health Investors's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	89.629	/	79.465	*	91
=	102.92

2. In Ben Graham's calculation of liquidation value, National Health Investors's accounts receivable are only considered to be worth 75% of book value:

National Health Investors's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	22.347	-	1214.433	+	0.75 * 89.629	+	0.5 * 0
=	-1,124.9

National Health Investors Change In Receivables Related Terms

Thank you for viewing the detailed overview of National Health Investors's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

National Health Investors (National Health Investors) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » National Health Investors Inc (NYSE:NHI) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

WX6:Germany

Address

222 Robert Rose Drive, Murfreesboro, TN, USA, 37129

Website

https://www.nhireit.com

National Health Investors Inc is a housing and medical facility REIT. The company operate through two reportable segments i.e. Real Estate Investments and Senior Housing Operating Portfolio. Real Estate Investments segment consists of real estate investments and lease, mortgage and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities and a hospital. SHOP segment is comprised of two ventures that own the operations of independent living facilities. Company's revenues are derived from rental income, mortgage and other notes receivable interest income and resident fees and services.

Executives

James R Jobe	director	707 REGAL DRIVE, MURFREESBORO TN 37129
Robert G Adams	director, officer: President	P.O. BOX 1398, MURFREESBORO TN 37133-1398
Colden Tracy M J	director	C/O PLAYA HOTELS & RESORTS N.V.,, 3950 UNIVERSITY DRIVE, SUITE 301, FAIRFAX VA 22030
Robert T Webb	director	PO BOX 1102, MURFREESBORO TN 37133-1102
D. Eric Mendelsohn	officer: EVP - Corporate Finance	C/O EMERITUS CORPORATION, 3131 ELLIOTT AVENUE, SUITE 500, SEATTLE WA 98121
Mccabe Robert A Jr	director	500 CHURCH ST, STE 200, NASHVILLE TN 37219
David L Travis	officer: SVP/Chief Accounting Officer	C/O MEDEQUITIES REALTY TRUST, 3100 WEST END AVENUE, SUITE 1000, NASHVILLE TN 37203
W Andrew Adams	director, officer: President	P.O. BOX 1398, MURFREESBORO TN 37133-1398
Kevin Carlton Pascoe	officer: EVP - Investments	222 ROBERT ROSE DRIVE, MURFREESBORO TN 37129
Ronald V Reel	officer: Chief Accounting Officer	222 ROBERT ROSE DRIVE, MURFREESBORO TN 37129
Kristin Sallee Gaines	officer: Chief Credit Officer	2320 LONDONDERRY DRIVE, MURFREESBORO TN 37129
John L Spaid	officer: Exec. VP of Finance	222 ROBERT ROSE DRIVE, MURFREESBORO TN 37129
Roger R Hopkins	officer: Chief Accounting Officer	2930 PRINCETON LANE, MURFREESBORO TN 37129
James Justin Hutchens	officer: President and COO	C/O VENTAS, INC., 353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Ted H Welch	director	PO BOX 1102, MURFREESBORO TN 37133-1102